Is This AI Drug Discovery Stock a Bargain?
Nanalyze
@nanalyzeAbout
Sick and tired of all the Foolish pundits out there trying to convince you they found "the next Microsoft?" You won't find any cheerleaders here because they get shown the door. Instead, you'll find risk-averse investment professionals who know the industry and all the pitfalls it comes with. Finance is boring as hell, so none of that price-to-earnings rubbish. We use easy-to-understand language that doesn't require the viewer to have any background in finance or tech This channel covers all the exciting technologies out there - robotics, IoT, synthetic biology, gene editing, electric vehicle, flying cars, quantum computers, you name it. And we have a lot of fun while doing so and sometimes get in trouble for taking the piss out of the French too much. Who doesn't? Countless people tell us our content is unlike anything out there in terms of quality. That's because each video is accompanied by a research piece that takes at least a day to produce. Subscribe and see for yourself.
Latest Posts
Video Description
AbCellera stock was a pandemic darling, with their first day of trading seeing a valuation of nearly $13 billion. The AI drug discovery stock - which we happen to like - has now tumbled over 90%, leaving investors wondering whether it's time to buy. We see a lot of appeal in a platform that can reduce the time it takes to bring drugs to market, especially one that was tested and proven in the times of the 'Rona. But why do they now only have six noteworthy molecules in the clinic? And why are four of them from a private company called NovaRock? There's a lot of uncertainty surrounding ABCL stock these days, and we need to see some more success before we decide to go long. RESEARCH PIECES USED IN THIS VIDEO: 1. Why ABCL Stock is Falling https://youtu.be/g7m-Gs9_UB8 2. AbCellera Stock: Why We Love the Uncertainty https://www.nanalyze.com/2022/03/abcellera-stock-uncertainty/ 3. AbCellera Stock – Turning Antibodies Into Drugs https://www.nanalyze.com/2021/05/abcellera-stock-antibodies-drugs/ 4. Four AI Drug Discovery Stocks On Sale – 50% Off https://www.nanalyze.com/2022/03/four-ai-drug-discovery-stocks/ CHAPTERS: 00:00 Intro 00:54 How it started 02:06 Valuing AbCellera 03:33 AbCellera's candidates 04:12 The Antibody Engine 06:13 Downstream revenue 08:33 Molecules in the clinic 10:18 Partners 13:45 Financials 14:13 Parting thoughts ABOUT US: This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand. Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/become-a-nanalyze-premium-subscriber/ DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise. $abcl #abcl #abcellera #drugdiscovery #aistocks
AI-Driven Investing Essentials
AI-recommended products based on this video
